Kuros Biosciences Ag Stock Revenue
KURN Stock | CHF 6.48 0.08 1.25% |
Kuros Biosciences AG fundamentals help investors to digest information that contributes to Kuros Biosciences' financial success or failures. It also enables traders to predict the movement of Kuros Stock. The fundamental analysis module provides a way to measure Kuros Biosciences' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Kuros Biosciences stock.
Kuros |
Kuros Biosciences AG Company Revenue Analysis
Kuros Biosciences' Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Current Kuros Biosciences Revenue | 13.81 M |
Most of Kuros Biosciences' fundamental indicators, such as Revenue, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Kuros Biosciences AG is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
Competition |
Based on the latest financial disclosure, Kuros Biosciences AG reported 13.81 M of revenue. This is 99.82% lower than that of the Healthcare sector and 98.14% lower than that of the Biotechnology industry. The revenue for all Switzerland stocks is 99.85% higher than that of the company.
Kuros Revenue Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Kuros Biosciences' direct or indirect competition against its Revenue to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Kuros Biosciences could also be used in its relative valuation, which is a method of valuing Kuros Biosciences by comparing valuation metrics of similar companies.Kuros Biosciences is currently under evaluation in revenue category among related companies.
Kuros Fundamentals
Return On Equity | -0.14 | |||
Return On Asset | -0.0667 | |||
Profit Margin | (0.74) % | |||
Operating Margin | (0.64) % | |||
Current Valuation | 38.12 M | |||
Shares Outstanding | 36.54 M | |||
Shares Owned By Insiders | 35.33 % | |||
Shares Owned By Institutions | 16.83 % | |||
Price To Book | 0.79 X | |||
Price To Sales | 3.63 X | |||
Revenue | 13.81 M | |||
Gross Profit | 10.07 M | |||
EBITDA | (5.29 M) | |||
Net Income | (7.54 M) | |||
Cash And Equivalents | 18.33 M | |||
Cash Per Share | 1.22 X | |||
Total Debt | 1.83 M | |||
Current Ratio | 4.91 X | |||
Book Value Per Share | 2.23 X | |||
Cash Flow From Operations | (5.45 M) | |||
Earnings Per Share | (0.23) X | |||
Target Price | 20.05 | |||
Number Of Employees | 64 | |||
Beta | 0.77 | |||
Market Capitalization | 52.08 M | |||
Total Asset | 91.34 M | |||
Z Score | 16.8 | |||
Net Asset | 91.34 M |
About Kuros Biosciences Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Kuros Biosciences AG's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Kuros Biosciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Kuros Biosciences AG based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Kuros Biosciences AG. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Complementary Tools for Kuros Stock analysis
When running Kuros Biosciences' price analysis, check to measure Kuros Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kuros Biosciences is operating at the current time. Most of Kuros Biosciences' value examination focuses on studying past and present price action to predict the probability of Kuros Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Kuros Biosciences' price. Additionally, you may evaluate how the addition of Kuros Biosciences to your portfolios can decrease your overall portfolio volatility.
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |